TWO SIGMA INVESTMENTS, LP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,701
-43.8%
10,876
-19.9%
0.00%
Q2 2023$15,477
-32.5%
13,576
-11.1%
0.00%
Q1 2023$22,914
-50.5%
15,276
-50.8%
0.00%
Q4 2022$46,303
-15.8%
31,076
-13.1%
0.00%
Q3 2022$55,000
-37.5%
35,776
-7.7%
0.00%
Q2 2022$88,000
-38.9%
38,776
-37.6%
0.00%
Q1 2022$144,000
-13.8%
62,184
+116.1%
0.00%
Q4 2021$167,000
-7.7%
28,771
+55.1%
0.00%
Q2 2021$181,000
-73.0%
18,551
-59.8%
0.00%
-100.0%
Q1 2021$670,00046,1120.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders